VENUS CONCEPT INC (VERO) Stock Price & Overview
NASDAQ:VERO • US92332W3034
Current stock price
The current stock price of VERO is 1.14 USD. Today VERO is down by -3.39%. In the past month the price decreased by -25.49%. In the past year, price decreased by -70.81%.
VERO Key Statistics
- Market Cap
- 2.12M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -48.84
- Dividend Yield
- N/A
VERO Stock Performance
VERO Stock Chart
VERO Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to VERO. When comparing the yearly performance of all stocks, VERO is a bad performer in the overall market: 95.5% of all stocks are doing better.
VERO Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to VERO. VERO has a bad profitability rating. Also its financial health evaluation is rather negative.
VERO Earnings
On November 13, 2025 VERO reported an EPS of -12.14 and a revenue of 13.78M. The company missed EPS expectations (-229.69% surprise) and missed revenue expectations (-6.74% surprise).
VERO Forecast & Estimates
For the next year, analysts expect an EPS growth of 76.72% and a revenue growth -9.41% for VERO
VERO Groups
Sector & Classification
VERO Financial Highlights
Over the last trailing twelve months VERO reported a non-GAAP Earnings per Share(EPS) of -48.84. The EPS increased by 44.64% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -88.62% | ||
| ROE | -2043.17% | ||
| Debt/Equity | 1.87 |
VERO Ownership
VERO Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 18.66 | 186.262B | ||
| ISRG | INTUITIVE SURGICAL INC | 46.96 | 170.438B | ||
| SYK | STRYKER CORP | 22.46 | 130.023B | ||
| BSX | BOSTON SCIENTIFIC CORP | 19.99 | 103.709B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.37 | 47.893B | ||
| IDXX | IDEXX LABORATORIES INC | 39.12 | 46.168B | ||
| BDX | BECTON DICKINSON AND CO | 11.48 | 44.57B | ||
| RMD | RESMED INC | 18.52 | 33.129B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 13.62 | 32.076B | ||
| DXCM | DEXCOM INC | 26.46 | 25.89B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.6 | 17.577B | ||
| HOLX | HOLOGIC INC | 15.35 | 16.817B | ||
| PODD | INSULET CORP | 35.36 | 16.096B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About VERO
Company Profile
Venus Concept, Inc. is a global medical technology company, which engages in the business of developing, commercializing, and selling minimally invasive and non-invasive medical aesthetic and hair restoration technologies. The company is headquartered in Toronto, Ontario and currently employs 292 full-time employees. The company went IPO on 2017-10-12. The firm develops, commercializes and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services and reaches over 60 countries and nine direct markets. The Company’s product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Versa Pro, Venus Legacy, Venus Velocity, Venus Viva, Venus Glow, Venus Bliss, Venus Bliss MAX, Venus Epileve, Venus Viva MD and AI.ME. Its treatments for hair loss are divided into non-surgical options and surgical procedures. Its hair restoration systems include NeoGraft and the ARTAS iX Robotic Hair Restoration system. Its systems are designed on flexible platforms that enable it to expand beyond the aesthetic industry’s traditional markets of dermatology and plastic surgery, and into non-traditional markets, including family medicine and general practitioners and aesthetic medical spas.
Company Info
IPO: 2017-10-12
VENUS CONCEPT INC
235 Yorkland Blvd Suite 900
TORONTO ONTARIO M2J 4Y8 CA
CEO: Domenic Serafino
Employees: 292
Phone: 18778488430
VENUS CONCEPT INC / VERO FAQ
What does VENUS CONCEPT INC do?
Venus Concept, Inc. is a global medical technology company, which engages in the business of developing, commercializing, and selling minimally invasive and non-invasive medical aesthetic and hair restoration technologies. The company is headquartered in Toronto, Ontario and currently employs 292 full-time employees. The company went IPO on 2017-10-12. The firm develops, commercializes and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services and reaches over 60 countries and nine direct markets. The Company’s product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Versa Pro, Venus Legacy, Venus Velocity, Venus Viva, Venus Glow, Venus Bliss, Venus Bliss MAX, Venus Epileve, Venus Viva MD and AI.ME. Its treatments for hair loss are divided into non-surgical options and surgical procedures. Its hair restoration systems include NeoGraft and the ARTAS iX Robotic Hair Restoration system. Its systems are designed on flexible platforms that enable it to expand beyond the aesthetic industry’s traditional markets of dermatology and plastic surgery, and into non-traditional markets, including family medicine and general practitioners and aesthetic medical spas.
What is the stock price of VENUS CONCEPT INC today?
The current stock price of VERO is 1.14 USD. The price decreased by -3.39% in the last trading session.
What is the dividend status of VENUS CONCEPT INC?
VERO does not pay a dividend.
How is the ChartMill rating for VENUS CONCEPT INC?
VERO has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Can you provide the growth outlook for VENUS CONCEPT INC?
The Revenue of VENUS CONCEPT INC (VERO) is expected to decline by -9.41% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
Can you provide the market cap for VENUS CONCEPT INC?
VENUS CONCEPT INC (VERO) has a market capitalization of 2.12M USD. This makes VERO a Nano Cap stock.